Contact us/ [email protected]
As the COVID-19 pandemic continues and the vaccine rollout proceeds at varying paces across the globe, organisations find themselves in different and sometimes multiple stages of the crisis management lifecycle. Using Control Risks’ Readiness, Response and Recovery methodology, we are helping clients navigate their way through the crisis by shaping responses that target rapid commercial recovery and factor in longer-term scenarios. We provide critical insights and advice on how to manage fast-moving information cycles and adapt your existing crisis recovery measures to new developments. Remaining flexible, agile, forward-thinking and empathetic are all essential for a successful outcome.
Readiness
In the race to get ahead of the next major crisis, data is king
The COVID-19 pandemic showed that companies need effective data analysis and monitoring to better plan for and manage crises and disruptions to business continuity. Read our three key points.
Response
Hurricane preparedness in the time of COVID-19
Hurricane forecasts and overall climate related trends indicate that we should expect another “above-normal” season of potentially devastating storms in the Americas. When coupled with the fact that many employees are still working remotely due to the pandemic, an intense hurricane season is an especially challenging crisis to plan for and manage.
Recovery
Pandemic will test Tokyo 2020 to the finish line – whenever that may be
The postponed summer event is currently scheduled to proceed. But doubts will likely linger to the last minute about whether it really is, and indeed, whether it should. We take a look at the risks to manage for all those involved in the event.
Recovery
COVID-19 vaccine diplomacy – from nationalism to friendship
Vaccine rollouts have begun quickly in some countries while others wait. We examine the divergent impacts on diplomatic relations between states prioritising domestic vaccination and others sharing their doses overseas.
Recovery
Navigating third-party risks in pharma and life sciences
Compliance leads at pharmaceutical and life sciences companies have one of the least navigable jobs in our field. The complexity and uncertainty surrounding the COVID-19 pandemic has presented an array of operational issues with third-party compliance.
Latest Podcast
The G7 response to COVID-19 offers no concrete path to global recovery.
Latest Situation Update
COVID-19 remains a threat to healthcare and business operations, and companies will need to think about their own restrictions.
Webinar
What does COVID-19 mean for your active crisis management programmes and what lies ahead for business?
COVID-19: Business Resumption
From crisis response to business resumption, optimise your approach to resumption planning with unique insights and tools.
Contact/ Our Experts
COVID-19 videos
Handling the information overload
Legal and compliance – 8 considerations
Related Articles
Business travel – cleared for take-off?
Managing remote terminations during COVID-19
COVID-19: Crisis management and threat management in a new era
COVID-19 “In-Flight” incident reviews - A prudent pause on the road to resumption
COVID-19: Business resumption framework
COVID-19: Insider risks to recovery and resilience
COVID-19: Taking the first steps to Recovery
Internal Investigations – Getting the basics right
COVID-19: What to focus on now, what to focus on next
COVID-19: Global Monitoring and Information Services
Control Risks’ Global Monitoring Information Services supports clients’ decision-making in response to the ongoing COVID-19 crisis. Services include trigger monitoring, email alerts, executive briefings and regional outlooks to ensure you can remain agile and empathetic as the situation evolves.
Leadership in the COVID-19 crisis
New global scenarios for COVID-19
COVID-19: The impact on workers in global supply chains
Crisis management in the midst of an emergent outbreak
Preparing for natural disasters in the time of COVID-19
Back to work the risks for business of returning employees to the workplace
Remote investigations during COVID-19
In this roundtable discussion, Andrew Weissmann of Jenner & Block joins Brian Mich, Mavis Tan, Michael Zimmern and Ching Liu discuss conducting remote investigations during COVID-19.